Royalty Pharma plc (RPRX)

Royalty Pharma Revenue

Royalty Pharma had revenue of $568.25M in the quarter ending March 31, 2025, with 0.05% growth. This brings the company's revenue in the last twelve months to $2.26B, up 1.13% year-over-year. In the year 2024, Royalty Pharma had annual revenue of $2.26B, down -3.86%.

• Revenue (ttm): $2.26B
• Revenue Growth: +1.13%
• P/S Ratio: 7.21
• Revenue / Employee: $22,867,121
• Employees: 99
• Market Cap: 20.62B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.26B	-90.98M	-3.86%
Dec 31, 2023	2.35B	117.34M	5.24%
Dec 31, 2022	2.24B	-52.25M	-2.28%
Dec 31, 2021	2.29B	167.11M	7.87%
Dec 31, 2020	2.12B	308.10M	16.98%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.